A detailed history of Winton Group LTD transactions in Castle Biosciences Inc stock. As of the latest transaction made, Winton Group LTD holds 16,526 shares of CSTL stock, worth $489,665. This represents 0.04% of its overall portfolio holdings.

Number of Shares
16,526
Holding current value
$489,665
% of portfolio
0.04%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$17.4 - $31.47 $287,552 - $520,073
16,526 New
16,526 $471,000
Q4 2021

Feb 10, 2022

SELL
$39.06 - $67.58 $179,949 - $311,341
-4,607 Closed
0 $0
Q3 2021

Oct 28, 2021

BUY
$60.13 - $77.6 $28,802 - $37,170
479 Added 11.6%
4,607 $306,000
Q2 2021

Aug 10, 2021

BUY
$50.07 - $76.78 $1,301 - $1,996
26 Added 0.63%
4,128 $303,000
Q1 2021

Jul 21, 2021

SELL
$58.92 - $97.33 $143,764 - $237,485
-2,440 Reduced 37.3%
4,102 $281,000
Q4 2020

Feb 12, 2021

BUY
$43.6 - $73.05 $46,085 - $77,213
1,057 Added 19.27%
6,542 $439,000
Q3 2020

Oct 30, 2020

BUY
$38.47 - $52.03 $211,007 - $285,384
5,485 New
5,485 $282,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $779M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.